TRANSITIONAL CELL CARCINOMA side effect
What is TRANSITIONAL CELL CARCINOMA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
TRANSITIONAL CELL CARCINOMA and Recently Reported Side Effects
TRANSITIONAL CELL CARCINOMA and 15 most Active Side Effect polls
TRANSITIONAL CELL CARCINOMA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with TRANSITIONAL CELL CARCINOMA
ACTOS DOXORUBICIN ENBREL ENDOXAN GENOTROPIN INTERFERON MABTHERA REMICADE RITUXAN RITUXIMABRituxan Side Effects Report #5685208-X
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 21, 2008. Female patient, weighting 202.8 lb, was diagnosed with glomerulonephritis membranous and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, . RITUXAN dosage: 768.75 MG, X4. During the same period patient was treated with CAPTOPRIL, METOPROLOL TARTRATE, DIOVAN, OMEPRAZOLE, BACTRIM, ASPIRIN. Patient was hospitalized. Patient recovered.
Genotropin Side Effects Report #5588060-6
GENOTROPIN problem was reported by a Consumer or non-health professional from NETHERLANDS on Jan 02, 2008. Male patient, 56 years of age, weighting 269.0 lb, was diagnosed with growth hormone deficiency and was treated with GENOTROPIN. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, . GENOTROPIN dosage: unknown. Patient was hospitalized. Patient recovered.
Genotropin Side Effects Report #5594082-1
Consumer or non-health professional from NETHERLANDS reported GENOTROPIN problem on Jan 08, 2008. Male patient, 56 years of age, weighting 269.0 lb, was diagnosed with growth hormone deficiency and was treated with GENOTROPIN. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, . GENOTROPIN dosage: unknown. During the same period patient was treated with FLIXONASE, PANTOPRAZOLE, LIPITOR. Patient was hospitalized. Patient recovered.
Enbrel Side Effects Report #5512945-X
ENBREL problem was reported by a Health Professional from UNITED KINGDOM on Nov 01, 2007. Female patient was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, . ENBREL dosage: 50 MG WEEKLY. Patient recovered.
Rituximab Side Effects Report #5427971-9
Physician from UNITED KINGDOM reported RITUXIMAB problem on Aug 21, 2007. Male patient, weighting 187.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, . RITUXIMAB dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Interferon Side Effects Report #5384874-6
INTERFERON GAMMA problem was reported by a Physician from UNITED STATES on June 21, 2007. Male patient, 74 years of age, weighting 206.4 lb, was diagnosed with idiopathic pulmonary fibrosis and was treated with INTERFERON GAMMA. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, tumour haemorrhage, white blood cells urine positive, . INTERFERON GAMMA dosage: unknown. During the same period patient was treated with RANITIDINE, ATORVASTATIN, HYDROCODONE W, AVANDIA, FENOFIBRATE, PARACETAMOL, FEXOFENADINE, ADVAIR DISKUS. Patient recovered.
Interferon Side Effects Report #5384874-6
Physician from UNITED STATES reported INTERFERON GAMMA problem on June 21, 2007. Male patient, 74 years of age, weighting 206.4 lb, was diagnosed with idiopathic pulmonary fibrosis and was treated with INTERFERON GAMMA. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, tumour haemorrhage, white blood cells urine positive, . INTERFERON GAMMA dosage: unknown. During the same period patient was treated with RANITIDINE, ATORVASTATIN, HYDROCODONE W, AVANDIA, FENOFIBRATE, PARACETAMOL, FEXOFENADINE, ADVAIR DISKUS. Patient recovered.
Rituximab Side Effects Report #5713057-2
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 01, 2008. Female patient, weighting 202.8 lb, was diagnosed with glomerulonephritis membranous and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, . RITUXIMAB dosage: 768.75 MG, X4. During the same period patient was treated with CAPTOPRIL, METOPROLOL TARTRATE, DIOVAN, OMEPRAZOLE, BACTRIM, ASPIRIN. Patient was hospitalized. Patient recovered.
Interferon Side Effects Report #5377866-4
Physician from UNITED STATES reported INTERFERON GAMMA problem on June 05, 2007. Male patient, 74 years of age, weighting 206.4 lb, was diagnosed with idiopathic pulmonary fibrosis and was treated with INTERFERON GAMMA. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, . INTERFERON GAMMA dosage: unknown. During the same period patient was treated with RANITIDINE, ATORVASTATIN, HYDROCODONE W, AVANDIA, FENOFIBRATE, PARACETAMOL, FEXOFENADINE, ADVAIR DISKUS. Patient recovered.
Remicade Side Effects Report #5317873-0
REMICADE problem was reported by a Physician from FRANCE on Apr 26, 2007. Male patient, 53 years of age, was diagnosed with ankylosing spondylitis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, . REMICADE dosage: unknown. During the same period patient was treated with CARTEX, DIANTALVIC. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5266814-3
Physician from FRANCE reported REMICADE problem on Mar 07, 2007. Male patient, 53 years of age, was diagnosed with ankylosing spondylitis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, . REMICADE dosage: unknown. Patient recovered.
Interferon Side Effects Report #5270583-0
INTERFERON GAMMA problem was reported by a Physician from UNITED STATES on Feb 28, 2007. Male patient, 74 years of age, weighting 206.4 lb, was diagnosed with idiopathic pulmonary fibrosis and was treated with INTERFERON GAMMA. After drug was administered, patient experienced the following problems/side effects: transitional cell carcinoma, tumour haemorrhage, . INTERFERON GAMMA dosage: unknown. During the same period patient was treated with RANITIDINE GAMMA, ATORVASTATIN CALCIUM, HYDROCODONE W, AVANDIA, FENOFIBRATE, ACETAMINOPHEN, FEXOFENADINE, ADVAIR DISKUS. Patient recovered.
Doxorubicin Side Effects Report #5397197-6
Health Professional from FRANCE reported DOXORUBICIN HYDROCHLORIDE problem on July 13, 2007. Male patient, 70 years of age, was diagnosed with lymphoma and was treated with DOXORUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, transitional cell carcinoma, . DOXORUBICIN HYDROCHLORIDE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, FLUDARA, MABTHERA, PEGINTERFERON ALFA, DIAMICRON, STAGID, TICLID. Patient recovered.
Doxorubicin Side Effects Report #5397197-6
DOXORUBICIN HYDROCHLORIDE problem was reported by a Health Professional from FRANCE on July 13, 2007. Male patient, 70 years of age, was diagnosed with lymphoma and was treated with DOXORUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, transitional cell carcinoma, . DOXORUBICIN HYDROCHLORIDE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, FLUDARA, MABTHERA, PEGINTERFERON ALFA, DIAMICRON, STAGID, TICLID. Patient recovered.
Actos Side Effects Report #5728175-2
Health Professional from UNITED STATES reported ACTOS problem on Apr 21, 2008. Male patient, 63 years of age, was diagnosed with diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: haematuria, transitional cell carcinoma, . ACTOS dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with VERAPAMIL, LIPITOR, ZESTORETIC, CARDURA. Patient recovered.
Endoxan Side Effects Report #5365610-6
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Male patient, 70 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, transitional cell carcinoma, . ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, DOXORUBICIN, FLUDARA, MABTHERA, PEGINTERFERON ALFA, DIAMICRON, STAGID, TICLID. Patient recovered.
Mabthera Side Effects Report #5266634-X
Physician from GERMANY reported MABTHERA problem on Feb 27, 2007. Male patient, 58 years of age, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: prostate cancer, transitional cell carcinoma, . MABTHERA dosage: unknown. Patient recovered.
Mabthera Side Effects Report #5266656-9
MABTHERA problem was reported by a Physician from GERMANY on Feb 27, 2007. Male patient, 57 years of age, weighting 176.4 lb, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: prostate cancer, transitional cell carcinoma, . MABTHERA dosage: unknown. Patient recovered.